Global and United States Parkinsons Disease Drug Market Report & Forecast 2022-2028

Global and United States Parkinsons Disease Drug Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Parkinsons Disease Drug Product Introduction
1.2 Global Parkinsons Disease Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Parkinsons Disease Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Parkinsons Disease Drug Sales in Volume for the Year 2017-2028
1.3 United States Parkinsons Disease Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Parkinsons Disease Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Parkinsons Disease Drug Sales in Volume for the Year 2017-2028
1.4 Parkinsons Disease Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Parkinsons Disease Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Parkinsons Disease Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Parkinsons Disease Drug Market Dynamics
1.5.1 Parkinsons Disease Drug Industry Trends
1.5.2 Parkinsons Disease Drug Market Drivers
1.5.3 Parkinsons Disease Drug Market Challenges
1.5.4 Parkinsons Disease Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Parkinsons Disease Drug Market Segment by Type
2.1.1 Carbidopa/Levodopa
2.1.2 Dopamine Receptor Agonists
2.1.3 MAO-Inhibitors
2.2 Global Parkinsons Disease Drug Market Size by Type
2.2.1 Global Parkinsons Disease Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Parkinsons Disease Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Parkinsons Disease Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Parkinsons Disease Drug Market Size by Type
2.3.1 United States Parkinsons Disease Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Parkinsons Disease Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Parkinsons Disease Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Parkinsons Disease Drug Market Segment by Application
3.1.1 Hospital
3.1.2 Clinics
3.1.3 Other
3.2 Global Parkinsons Disease Drug Market Size by Application
3.2.1 Global Parkinsons Disease Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Parkinsons Disease Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Parkinsons Disease Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Parkinsons Disease Drug Market Size by Application
3.3.1 United States Parkinsons Disease Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Parkinsons Disease Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Parkinsons Disease Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Parkinsons Disease Drug Competitor Landscape by Company
4.1 Global Parkinsons Disease Drug Market Size by Company
4.1.1 Top Global Parkinsons Disease Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Parkinsons Disease Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Parkinsons Disease Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Parkinsons Disease Drug Price by Manufacturer (2017-2022)
4.2 Global Parkinsons Disease Drug Concentration Ratio (CR)
4.2.1 Parkinsons Disease Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Parkinsons Disease Drug in 2021
4.2.3 Global Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Parkinsons Disease Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Parkinsons Disease Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Parkinsons Disease Drug Product Type
4.3.3 Date of International Manufacturers Enter into Parkinsons Disease Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Parkinsons Disease Drug Market Size by Company
4.5.1 Top Parkinsons Disease Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Parkinsons Disease Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Parkinsons Disease Drug Sales by Players (2020, 2021 & 2022)
5 Global Parkinsons Disease Drug Market Size by Region
5.1 Global Parkinsons Disease Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Parkinsons Disease Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Parkinsons Disease Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Parkinsons Disease Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Parkinsons Disease Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Parkinsons Disease Drug Sales in Value by Region: 2017-2022
5.3.2 Global Parkinsons Disease Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Parkinsons Disease Drug Market Size YoY Growth 2017-2028
6.1.2 North America Parkinsons Disease Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Parkinsons Disease Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Parkinsons Disease Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Parkinsons Disease Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Parkinsons Disease Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Parkinsons Disease Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Parkinsons Disease Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Parkinsons Disease Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Parkinsons Disease Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Teva
7.1.1 Teva Corporation Information
7.1.2 Teva Description and Business Overview
7.1.3 Teva Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Teva Parkinsons Disease Drug Products Offered
7.1.5 Teva Recent Development
7.2 Novartis AG
7.2.1 Novartis AG Corporation Information
7.2.2 Novartis AG Description and Business Overview
7.2.3 Novartis AG Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Novartis AG Parkinsons Disease Drug Products Offered
7.2.5 Novartis AG Recent Development
7.3 GSK
7.3.1 GSK Corporation Information
7.3.2 GSK Description and Business Overview
7.3.3 GSK Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 GSK Parkinsons Disease Drug Products Offered
7.3.5 GSK Recent Development
7.4 AbbVie
7.4.1 AbbVie Corporation Information
7.4.2 AbbVie Description and Business Overview
7.4.3 AbbVie Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 AbbVie Parkinsons Disease Drug Products Offered
7.4.5 AbbVie Recent Development
7.5 Merck
7.5.1 Merck Corporation Information
7.5.2 Merck Description and Business Overview
7.5.3 Merck Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Merck Parkinsons Disease Drug Products Offered
7.5.5 Merck Recent Development
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporation Information
7.6.2 Boehringer Ingelheim Description and Business Overview
7.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Boehringer Ingelheim Parkinsons Disease Drug Products Offered
7.6.5 Boehringer Ingelheim Recent Development
7.7 Impax Laboratories
7.7.1 Impax Laboratories Corporation Information
7.7.2 Impax Laboratories Description and Business Overview
7.7.3 Impax Laboratories Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Impax Laboratories Parkinsons Disease Drug Products Offered
7.7.5 Impax Laboratories Recent Development
7.8 Lundbeck
7.8.1 Lundbeck Corporation Information
7.8.2 Lundbeck Description and Business Overview
7.8.3 Lundbeck Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Lundbeck Parkinsons Disease Drug Products Offered
7.8.5 Lundbeck Recent Development
7.9 Sun Pharma
7.9.1 Sun Pharma Corporation Information
7.9.2 Sun Pharma Description and Business Overview
7.9.3 Sun Pharma Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Sun Pharma Parkinsons Disease Drug Products Offered
7.9.5 Sun Pharma Recent Development
7.10 Wockhardt
7.10.1 Wockhardt Corporation Information
7.10.2 Wockhardt Description and Business Overview
7.10.3 Wockhardt Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Wockhardt Parkinsons Disease Drug Products Offered
7.10.5 Wockhardt Recent Development
7.11 UCB
7.11.1 UCB Corporation Information
7.11.2 UCB Description and Business Overview
7.11.3 UCB Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.11.4 UCB Parkinsons Disease Drug Products Offered
7.11.5 UCB Recent Development
7.12 Bausch Health
7.12.1 Bausch Health Corporation Information
7.12.2 Bausch Health Description and Business Overview
7.12.3 Bausch Health Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Bausch Health Products Offered
7.12.5 Bausch Health Recent Development
7.13 Acadia
7.13.1 Acadia Corporation Information
7.13.2 Acadia Description and Business Overview
7.13.3 Acadia Parkinsons Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Acadia Products Offered
7.13.5 Acadia Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Parkinsons Disease Drug Industry Chain Analysis
8.2 Parkinsons Disease Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Parkinsons Disease Drug Distributors
8.3 Parkinsons Disease Drug Production Mode & Process
8.4 Parkinsons Disease Drug Sales and Marketing
8.4.1 Parkinsons Disease Drug Sales Channels
8.4.2 Parkinsons Disease Drug Distributors
8.5 Parkinsons Disease Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Parkinsons Disease Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Parkinsons Disease Drug Market Trends
Table 3. Parkinsons Disease Drug Market Drivers
Table 4. Parkinsons Disease Drug Market Challenges
Table 5. Parkinsons Disease Drug Market Restraints
Table 6. Global Parkinsons Disease Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Parkinsons Disease Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Parkinsons Disease Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Parkinsons Disease Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Parkinsons Disease Drug Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Parkinsons Disease Drug Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Parkinsons Disease Drug Revenue Share by Manufacturer, 2017-2022
Table 13. Global Parkinsons Disease Drug Sales by Manufacturer, (K Doses), 2017-2022
Table 14. Global Parkinsons Disease Drug Sales Share by Manufacturer, 2017-2022
Table 15. Global Parkinsons Disease Drug Price by Manufacturer (2017-2022) & (USD/Dose)
Table 16. Global Parkinsons Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Parkinsons Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2021)
Table 18. Top Players of Parkinsons Disease Drug in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Parkinsons Disease Drug Product Type
Table 20. Date of International Manufacturers Enter into Parkinsons Disease Drug Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Parkinsons Disease Drug Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Parkinsons Disease Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Parkinsons Disease Drug Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Parkinsons Disease Drug Sales by Players, (K Doses), 2020, 2021 & 2022
Table 26. United States Parkinsons Disease Drug Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Parkinsons Disease Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Parkinsons Disease Drug Sales in Volume by Region (2017-2022) & (K Doses)
Table 29. Global Parkinsons Disease Drug Sales in Volume Forecast by Region (2023-2028) & (K Doses)
Table 30. Global Parkinsons Disease Drug Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Parkinsons Disease Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Parkinsons Disease Drug Sales in Volume by Country (2017-2028) & (K Doses)
Table 33. North America Parkinsons Disease Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Parkinsons Disease Drug Sales in Volume by Region (2017-2028) & (K Doses)
Table 35. Asia Pacific Parkinsons Disease Drug Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Parkinsons Disease Drug Sales in Volume by Country (2017-2028) & (K Doses)
Table 37. Europe Parkinsons Disease Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Parkinsons Disease Drug Sales in Volume by Country (2017-2028) & (K Doses)
Table 39. Latin Americaa Parkinsons Disease Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Parkinsons Disease Drug Sales in Volume by Country (2017-2028) & (K Doses)
Table 41. Middle East and Africa Parkinsons Disease Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Teva Corporation Information
Table 43. Teva Description and Business Overview
Table 44. Teva Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 45. Teva Parkinsons Disease Drug Product
Table 46. Teva Recent Development
Table 47. Novartis AG Corporation Information
Table 48. Novartis AG Description and Business Overview
Table 49. Novartis AG Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 50. Novartis AG Product
Table 51. Novartis AG Recent Development
Table 52. GSK Corporation Information
Table 53. GSK Description and Business Overview
Table 54. GSK Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 55. GSK Product
Table 56. GSK Recent Development
Table 57. AbbVie Corporation Information
Table 58. AbbVie Description and Business Overview
Table 59. AbbVie Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 60. AbbVie Product
Table 61. AbbVie Recent Development
Table 62. Merck Corporation Information
Table 63. Merck Description and Business Overview
Table 64. Merck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 65. Merck Product
Table 66. Merck Recent Development
Table 67. Boehringer Ingelheim Corporation Information
Table 68. Boehringer Ingelheim Description and Business Overview
Table 69. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 70. Boehringer Ingelheim Product
Table 71. Boehringer Ingelheim Recent Development
Table 72. Impax Laboratories Corporation Information
Table 73. Impax Laboratories Description and Business Overview
Table 74. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 75. Impax Laboratories Product
Table 76. Impax Laboratories Recent Development
Table 77. Lundbeck Corporation Information
Table 78. Lundbeck Description and Business Overview
Table 79. Lundbeck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 80. Lundbeck Product
Table 81. Lundbeck Recent Development
Table 82. Sun Pharma Corporation Information
Table 83. Sun Pharma Description and Business Overview
Table 84. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 85. Sun Pharma Product
Table 86. Sun Pharma Recent Development
Table 87. Wockhardt Corporation Information
Table 88. Wockhardt Description and Business Overview
Table 89. Wockhardt Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 90. Wockhardt Product
Table 91. Wockhardt Recent Development
Table 92. UCB Corporation Information
Table 93. UCB Description and Business Overview
Table 94. UCB Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 95. UCB Product
Table 96. UCB Recent Development
Table 97. Bausch Health Corporation Information
Table 98. Bausch Health Description and Business Overview
Table 99. Bausch Health Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 100. Bausch Health Product
Table 101. Bausch Health Recent Development
Table 102. Acadia Corporation Information
Table 103. Acadia Description and Business Overview
Table 104. Acadia Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 105. Acadia Product
Table 106. Acadia Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Parkinsons Disease Drug Customers List
Table 110. Parkinsons Disease Drug Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinsons Disease Drug Product Picture
Figure 2. Global Parkinsons Disease Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Parkinsons Disease Drug Market Size 2017-2028 (US$ Million)
Figure 4. Global Parkinsons Disease Drug Sales 2017-2028 (K Doses)
Figure 5. United States Parkinsons Disease Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Parkinsons Disease Drug Market Size 2017-2028 (US$ Million)
Figure 7. United States Parkinsons Disease Drug Sales 2017-2028 (K Doses)
Figure 8. United States Parkinsons Disease Drug Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Parkinsons Disease Drug Market Share in Global, in Volume (K Doses) 2017-2028
Figure 10. Parkinsons Disease Drug Report Years Considered
Figure 11. Product Picture of Carbidopa/Levodopa
Figure 12. Product Picture of Dopamine Receptor Agonists
Figure 13. Product Picture of MAO-Inhibitors
Figure 14. Global Parkinsons Disease Drug Market Share by Type in 2022 & 2028
Figure 15. Global Parkinsons Disease Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Parkinsons Disease Drug Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Parkinsons Disease Drug Sales by Type (2017-2028) & (K Doses)
Figure 18. Global Parkinsons Disease Drug Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Parkinsons Disease Drug Price by Type (2017-2028) & (USD/Dose)
Figure 20. United States Parkinsons Disease Drug Market Share by Type in 2022 & 2028
Figure 21. United States Parkinsons Disease Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Parkinsons Disease Drug Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Parkinsons Disease Drug Sales by Type (2017-2028) & (K Doses)
Figure 24. United States Parkinsons Disease Drug Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Parkinsons Disease Drug Price by Type (2017-2028) & (USD/Dose)
Figure 26. Product Picture of Hospital
Figure 27. Product Picture of Clinics
Figure 28. Product Picture of Other
Figure 29. Global Parkinsons Disease Drug Market Share by Application in 2022 & 2028
Figure 30. Global Parkinsons Disease Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Parkinsons Disease Drug Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Parkinsons Disease Drug Sales by Application (2017-2028) & (K Doses)
Figure 33. Global Parkinsons Disease Drug Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Parkinsons Disease Drug Price by Application (2017-2028) & (USD/Dose)
Figure 35. United States Parkinsons Disease Drug Market Share by Application in 2022 & 2028
Figure 36. United States Parkinsons Disease Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Parkinsons Disease Drug Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Parkinsons Disease Drug Sales by Application (2017-2028) & (K Doses)
Figure 39. United States Parkinsons Disease Drug Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Parkinsons Disease Drug Price by Application (2017-2028) & (USD/Dose)
Figure 41. North America Parkinsons Disease Drug Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 42. North America Parkinsons Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Parkinsons Disease Drug Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 46. Europe Parkinsons Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Parkinsons Disease Drug Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 53. Asia-Pacific Parkinsons Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Parkinsons Disease Drug Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 65. Latin America Parkinsons Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Parkinsons Disease Drug Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 70. Middle East & Africa Parkinsons Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Parkinsons Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Parkinsons Disease Drug Value Chain
Figure 75. Parkinsons Disease Drug Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs